'Eli Lilly (LLY) Extends Its Lead Into 2026'; PT Raised to $1,300 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Evan Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $1,300.00 (from $1,200.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
